Cours actuels de Dermata Therapeutics, Inc. - Warrant

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
NASDAQ	DRMAW	USD	12.06.2025 19:05	0,02 USD	0,02 USD +1,14 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	14,94 %	-12,81 %	-11,50 %	60,91 %	152,86 %	-98,41 %

Company Profile for Dermata Therapeutics, Inc. - Warrant Share

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California.

Company Data

Name Dermata Therapeutics, Inc. - Warrant

Company Dermata Therapeutics, Inc.

Symbol DRMAW

Website http://www.dermatarx.com

Primary Exchange

NASDAQ

ISIN US2498451168

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Gerald T. Proehl

Country United States of America

Currency USD

Employees 0,0 T

Address 3525 Del Mar Heights Road, 92130 San Diego

IPO Date 2021-08-13

Ticker Symbols

Name	Symbol
NASDAQ	DRMAW

More Shares

Investors who Dermata Therapeutics, Inc. - Warrant hold also have the following shares in their portfolio:

ASAHI GROUP 20/28 Bond

MUL-LYX.MSCI WCS TRUE AEO ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog